Department of Health Economics, School of Management and Medical Informatics, Tabriz University of Medical Sciences, Tabriz, Iran.
Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.
BMC Health Serv Res. 2024 Nov 28;24(1):1501. doi: 10.1186/s12913-024-11847-7.
Breast cancer is the most common diagnosed disease, and the second leading cause of death among women. Thus, due to its importance, the current research is aimed at identifying the preferences of individuals for improving breast cancer screening programs and the related policies.
A systematic search was applied on databases including - PubMed, Scopus, the Web of Science, Embase, Cochrane, SID- up to October 2022. The including articles were original or review papers that assessed individuals' willingness to pay. Also, articles including the effective variables or attributes for breast cancer screening program were included. Meta-analysis was applied to calculate Willingness to Pay (WTP) as a mean for breast cancer screening followed by vote-counting for identifying the variables and attributes correlated with screening.
A total of 721 articles were identified during the first phase. After the screening process, thirteen papers were chosen, out of which, nine assessed mammography as a breast cancer screening program. The results of random effect meta-analysis on the including studies indicated that the rate of willingness to pay for screening was 0.28% of GDP per capita (95%CI: 0.14-0.43), which was found to be statistically significant. The result of stratified meta- analysis indicated that the rate of willingness to pay for screening was 0.22% of GDP per capita (95%CI: 0.07-0.37), which was found to be statistically significant. Generally, income was the basic factor for receiving screening services, and cost was an effective attribute for participating in screening programs.
To increase women's participation in breast cancer screening programs; it is essential to provide legitimate information and eliminate the barriers to women's non-participation. Offering rapid tests at low costs in healthcare centers (both in terms of travel and screening time) delivered by female staff can lead to an increase in women's willingness to participate in breast cancer screening programs.
乳腺癌是最常见的诊断疾病，也是女性死亡的第二大主要原因。因此，由于其重要性，目前的研究旨在确定个人对改善乳腺癌筛查计划和相关政策的偏好。
对包括 PubMed、Scopus、Web of Science、Embase、Cochrane、SID 在内的数据库进行了系统搜索，截至 2022 年 10 月。纳入的文章为评估个人支付意愿的原始或综述论文。此外，还纳入了乳腺癌筛查计划的有效变量或属性的文章。应用荟萃分析计算乳腺癌筛查的支付意愿（WTP）作为均值，然后进行票数计数以确定与筛查相关的变量和属性。
在第一阶段共确定了 721 篇文章。经过筛选过程，选择了 13 篇论文，其中 9 篇评估了 mammography 作为乳腺癌筛查计划。对纳入研究的随机效应荟萃分析结果表明，筛查的支付意愿率为人均 GDP 的 0.28%（95%CI：0.14-0.43），具有统计学意义。分层荟萃分析的结果表明，筛查的支付意愿率为人均 GDP 的 0.22%（95%CI：0.07-0.37），具有统计学意义。一般来说，收入是获得筛查服务的基本因素，而成本是参与筛查计划的有效属性。
为了提高妇女参与乳腺癌筛查计划的意愿；必须提供合法的信息并消除妇女不参与的障碍。在医疗保健中心（无论是旅行还是筛查时间）以低成本提供快速测试，并由女性工作人员进行，可以提高妇女参与乳腺癌筛查计划的意愿。
